Episode 139: New Advances for Triple-Negative Breast Cancer Patients

Today, we're speaking with Dr. Neil Vasan, an assistant professor in the Department of Medicine, Division of Hematology Oncology at Columbia University Medial Center. Dr. Vasan is a physician scientist who studies how proteins function in breast cancer cell signaling and how treatments impact breast cancer cell signaling, which is the communication within a cell. His research has been published in top scientific journals including Science, Nature Cancer, Cancer Cell, and Cancer Discovery and he's received multiple awards, including being selected as a next gen star of the American Association for Cancer Research. Today, we're going to be discussing exciting new developments in the treatment of triple negative breast cancer. Dr. Vasan, welcome to the show!